Filing Details
- Accession Number:
- 0001209191-17-028279
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-04-26 20:17:50
- Reporting Period:
- 2017-04-24
- Filing Date:
- 2017-04-26
- Accepted Time:
- 2017-04-26 20:17:50
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1628738 | Audentes Therapeutics Inc. | BOLD | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1219014 | M Scott Rocklage | 501 Second Street, Suite 350 San Francisco CA 94107 | No | No | No | Yes | |
1240357 | D John Diekman | 501 Second Street, Suite 350 San Francisco CA 94107 | No | No | No | Yes | |
1456890 | 5Am Ventures Iii, L.p. | 501 Second Street, Suite 350 San Francisco CA 94107 | No | No | No | Yes | |
1478660 | 5Am Co-Investors Iii, L.p. | 501 Second Street, Suite 350 San Francisco CA 94107 | No | No | No | Yes | |
1555953 | 5Am Partners Iii, Llc | 501 Second Street, Suite 350 San Francisco CA 94107 | No | No | No | Yes | |
1598549 | J. Andrew Schwab | 501 Second Street, Suite 350 San Francisco CA 94107 | No | No | No | Yes |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2017-04-24 | 4,331 | $14.50 | 64,431 | No | 4 | P | Indirect | By 5AM Co-Investors III, L.P. |
Common Stock | Acquisiton | 2017-04-24 | 168,082 | $14.50 | 2,500,113 | No | 4 | P | Indirect | By 5AM Ventures III, L.P. |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | By 5AM Co-Investors III, L.P. |
No | 4 | P | Indirect | By 5AM Ventures III, L.P. |
Footnotes
- 5AM Partners III, LLC is the general partner of 5AM Ventures III, L.P. and 5AM Co-Investors III, L.P. Dr. John Diekman, Andrew Schwab and Dr. Scott Rocklage are the managing members of 5AM Partners III. 5AM Partners III, LLC may be deemed to have sole voting and investment power over the shares beneficially owned by 5AM Ventures III, L.P. and 5AM Co-Investors III, L.P. Dr. Diekman, Mr. Schwab and Dr. Rocklage may be deemed to have shared voting and investment power over the shares beneficially owned by 5AM Ventures III, L.P. and 5AM Co-Investors III, L.P. Each of 5AM Partners III, LLC, Dr. Diekman, Mr. Schwab and Dr. Rocklage disclaim beneficial ownership of such shares, except to the extent of its pecuniary interest therein.